Prognostic value of CD146 in solid tumor: A Systematic Review and Meta-analysis
Abstract CD146, also known as melanoma cell adhesion molecule, was initially identified as a marker of melanoma progression and metastasis. Recently many clinical studies investigated overexpression of CD146 predict poor prognosis of solid tumor, however, the results was inconclusive, partly due to...
Guardado en:
Autores principales: | , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3d9180d5f20a43069f422a82c37728da |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:3d9180d5f20a43069f422a82c37728da |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:3d9180d5f20a43069f422a82c37728da2021-12-02T11:41:00ZPrognostic value of CD146 in solid tumor: A Systematic Review and Meta-analysis10.1038/s41598-017-01061-32045-2322https://doaj.org/article/3d9180d5f20a43069f422a82c37728da2017-06-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-01061-3https://doaj.org/toc/2045-2322Abstract CD146, also known as melanoma cell adhesion molecule, was initially identified as a marker of melanoma progression and metastasis. Recently many clinical studies investigated overexpression of CD146 predict poor prognosis of solid tumor, however, the results was inconclusive, partly due to small numbers of patients included. This present meta-analysis was therefore performed utilizing the results of all clinical studies concerned to determine the prognostic value of CD146 expression in solid tumors. Relevant articles were identified through searching the PubMed, Web of Science and Embase database. In this meta-analysis, 12 studies involving 2,694 participants were included, and we drew the conclusion that strong significant associations between CD146 expression and all endpoints: overall survival (OS) [hazard ratio (HR) = 2.496, 95% confidence interval (95% CI) 2.115–2.946], time to progression (TTP) (HR = 2.445, 95% CI 1.975–3.027). Furthermore, the subgroup analysis revealed that the associations between CD146 overexpression and the outcome endpoints (OS or TTP) were significant in Mongoloid patients and Caucasian patients, as well in patients with lung cancer and digestive system cancer. In conclusion, these results showed that high CD146 was associated with poor survival in human solid tumors. CD146 may be a valuable prognosis predictive biomarker; nevertheless, whether CD146 could be a potential therapeutic target in human solid tumors needs to be further studied.Ping ZengHai LiPei-Hua LuLi-Na ZhouMin TangChao-Ying LiuMin-Bin ChenNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-7 (2017) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Ping Zeng Hai Li Pei-Hua Lu Li-Na Zhou Min Tang Chao-Ying Liu Min-Bin Chen Prognostic value of CD146 in solid tumor: A Systematic Review and Meta-analysis |
description |
Abstract CD146, also known as melanoma cell adhesion molecule, was initially identified as a marker of melanoma progression and metastasis. Recently many clinical studies investigated overexpression of CD146 predict poor prognosis of solid tumor, however, the results was inconclusive, partly due to small numbers of patients included. This present meta-analysis was therefore performed utilizing the results of all clinical studies concerned to determine the prognostic value of CD146 expression in solid tumors. Relevant articles were identified through searching the PubMed, Web of Science and Embase database. In this meta-analysis, 12 studies involving 2,694 participants were included, and we drew the conclusion that strong significant associations between CD146 expression and all endpoints: overall survival (OS) [hazard ratio (HR) = 2.496, 95% confidence interval (95% CI) 2.115–2.946], time to progression (TTP) (HR = 2.445, 95% CI 1.975–3.027). Furthermore, the subgroup analysis revealed that the associations between CD146 overexpression and the outcome endpoints (OS or TTP) were significant in Mongoloid patients and Caucasian patients, as well in patients with lung cancer and digestive system cancer. In conclusion, these results showed that high CD146 was associated with poor survival in human solid tumors. CD146 may be a valuable prognosis predictive biomarker; nevertheless, whether CD146 could be a potential therapeutic target in human solid tumors needs to be further studied. |
format |
article |
author |
Ping Zeng Hai Li Pei-Hua Lu Li-Na Zhou Min Tang Chao-Ying Liu Min-Bin Chen |
author_facet |
Ping Zeng Hai Li Pei-Hua Lu Li-Na Zhou Min Tang Chao-Ying Liu Min-Bin Chen |
author_sort |
Ping Zeng |
title |
Prognostic value of CD146 in solid tumor: A Systematic Review and Meta-analysis |
title_short |
Prognostic value of CD146 in solid tumor: A Systematic Review and Meta-analysis |
title_full |
Prognostic value of CD146 in solid tumor: A Systematic Review and Meta-analysis |
title_fullStr |
Prognostic value of CD146 in solid tumor: A Systematic Review and Meta-analysis |
title_full_unstemmed |
Prognostic value of CD146 in solid tumor: A Systematic Review and Meta-analysis |
title_sort |
prognostic value of cd146 in solid tumor: a systematic review and meta-analysis |
publisher |
Nature Portfolio |
publishDate |
2017 |
url |
https://doaj.org/article/3d9180d5f20a43069f422a82c37728da |
work_keys_str_mv |
AT pingzeng prognosticvalueofcd146insolidtumorasystematicreviewandmetaanalysis AT haili prognosticvalueofcd146insolidtumorasystematicreviewandmetaanalysis AT peihualu prognosticvalueofcd146insolidtumorasystematicreviewandmetaanalysis AT linazhou prognosticvalueofcd146insolidtumorasystematicreviewandmetaanalysis AT mintang prognosticvalueofcd146insolidtumorasystematicreviewandmetaanalysis AT chaoyingliu prognosticvalueofcd146insolidtumorasystematicreviewandmetaanalysis AT minbinchen prognosticvalueofcd146insolidtumorasystematicreviewandmetaanalysis |
_version_ |
1718395456370769920 |